Literature DB >> 8844453

Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.

N Dávila1, M Moreira-Andrés, J Alcañiz, B Barceló.   

Abstract

The causes for growth failure in children with idiopathic short stature (ISS) are not definitely established. Peripheral GH resistance due to changes at the level of the GH receptor has been suggested as one of the most probable explanation. In this study, we have selected a group of prepubertal children with ISS to evaluate the GHBP/receptor status by measuring the GH binding protein (GHBP) activity in plasma. Thirty prepubertal children with ISS (18 boys and 12 girls; age range: 4.79 to 11.33 yr) and twenty age-matched children with normal growth (11 boys and 9 girls) were studied. The ISS group presented growth retardation of -2.3 +/- 0.43 SD score (mean +/- SD) and normal GH secretion. Plasma IGF-I levels were below or in the low normal range (mean +/- SD: 136.3 +/- 62.3 micrograms/l, a concentration that was significantly different from IGF-I levels in the normal group (mean +/- SD: 187 +/- 57.5 micrograms/l p < 0.005). Plasma GHBP activity using a GH-binding/gel chromatography assay showed significantly lower values in ISS group (mean +/- SD: 7.17 +/- 1.5%) as compared with those of the control group (mean +/- SD: 12.02 +/- 2.04%; p < 0.001). There were no significant age- or sex-related differences in GHBP values in either group. The decreased GHBP levels observed in this group of children with ISS suggest that they may present a certain degree of GH insensitivity, probably due to a defect at the GH-receptor level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844453     DOI: 10.1007/BF03344968

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.

Authors:  R M Blizzard; A D Rogol; P M Martha; J L Kirkland; B M Sherman
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

2.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Do short children secrete insufficient growth hormone?

Authors:  Z Zadik; S A Chalew; S Raiti; A A Kowarski
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

4.  Diverse growth hormone receptor gene mutations in Laron syndrome.

Authors:  M A Berg; J Argente; S Chernausek; R Gracia; J Guevara-Aguirre; M Hopp; L Pérez-Jurado; A Rosenbloom; S P Toledo; U Francke
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

5.  Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study.

Authors:  L M Carlsson; K M Attie; P G Compton; R V Vitangcol; T J Merimee
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

6.  Analyses of 24-hour growth hormone profiles in children: relation to growth.

Authors:  K Albertsson-Wikland; S Rosberg
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. I. Serum growth hormone-binding protein.

Authors:  P M Martha; A D Rogol; L M Carlsson; N Gesundheit; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

8.  The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development.

Authors:  W H Daughaday; B Trivedi; B A Andrews
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

9.  Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight.

Authors:  A Silbergeld; L Lazar; B Erster; R Keret; R Tepper; Z Laron
Journal:  Clin Endocrinol (Oxf)       Date:  1989-09       Impact factor: 3.478

10.  Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome.

Authors:  S Amselem; P Duquesnoy; B Duriez; F Dastot; M L Sobrier; S Valleix; M Goossens
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.